Document text
Principal Investigator: DAVE ANNETTE
Organization: INFORMATION MANAGEMENT SERVICES, INC.
Fiscal Year: 2023
Award: $842,461
Funding agency: National Cancer Institute
The National Cancer Institute (NCI) is an institute within the National Institutes of Health (NIH), one of eight agencies that compose the Public Health Service (PHS), Department of Health and Human Services (DHHS). The mission of the NCI is to plan, conduct, and coordinate the National Cancer program and involves (a) research on the causes, detection, diagnosis, prevention, treatment, and palliative care of cancers and on rehabilitation of the cancer patient and (b) demonstration of the effectiveness of cancer control methods and techniques.
II. Background
The Division of Cancer Treatment and Diagnosis (DCTD) of the NCI has initiated a natural history study, NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study to investigate the course of disease in cancer patients with positive test results for SARS-CoV-2, the virus that causes the
disease COVID-19. Across the NCI’s clinical trials networks, patients who enroll will have clinical data, imaging data and longitudinal blood or other biospecimens collected over a two-year period for laboratory analysis. NCI will use its existing Medidata Rave system to acquire and manage the clinical data and the Imaging and Radiation Oncology Core (IROC) to manage the imaging data. Several different kinds of laboratory analyses are planned to investigate biological aspects of the disease, including but not limited to genomics, serology, and immune response, and to examine associations of biological features with clinical variables and outcomes. Laboratory studies will take place at multiple institutions,
both at NCI-Frederick and at several non-government academic and commercial laboratories. The data analysis effort will be led by the Biometric Research Program (BRP) in DCTD, in collaboration with the participating laboratories and other members of the study team.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Abscission><Active Follow-up><Address><Adopted><Assay><Bioassay><Biologic Assays><Biological><Biological Assay><Biological Markers><Biometrics><Biometry><Biostatistics><Blood><Blood Reticuloendothelial System><COVID-19><COVID-19 virus><COVID19><COVID19 virus><CV-19><CV19><Cancer Control><Cancer Control Science><Cancer Patient><Characteristics><Clinical><Clinical Data><Clinical Management><Clinical Trials><Clinical Trials Network><CoV-2><CoV2><Collaborations><Communication><Computers><Consult><Consultations><Contractor><Custom><Data><Data Analyses><Data Analysis><Data Banks><Data Bases><Data Collection><Data Commons><Data Element><Data Files><Data Security><Data Set><Data awareness><Databanks><Databases><Department of Health and Human Services><Detection><Development><Diagnosis><Disease><Disorder><Division of Cancer Treatment and Diagnosis><Documentation><E-Mail><EXTMR><Effectiveness><Electronic Mail><Electronics><Email><Enrollment><Ensure><Event><Excision><Extirpation><Extramural><Extramural Activities><Failure><Frequencies><Generations><Genomics><Grant><Group Meetings><Human Resources><Image><Immune response><Immunological response><Individual><Institution><Investigators><Laboratories><Laboratory Study><Length><Link><Logic><Logistics><Manpower><Manuals><Master of Science><Master's Degree><Medidata><Methods><Mission><Modification><Molecular Analysis><Monitor><NCI Organization><NIH><Names><National Cancer Institute><National Cancer Program><National Institutes of Health><Natural History><On-Line Systems><Online Systems><Outcome><Patients><Performance><Phone><Positive Test Result><Preparation><Prevention><Process><Production><Public Health Service><Quality Control><Radiation Oncology><Recurrence><Recurrent><Removal><Reporting><Research><Research Personnel><Research Resources><Research Specimen><Researchers><Resources><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Secure><Serology><Services><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Shipping><Specific qualifier value><Specified><Specimen><Statistical Data Analyses><Statistical Data Analysis><Statistical Data Interpretation><Structure><Support Contracts><Surgical Removal><System><Techniques><Telephone><Text><Time><USPHS><United States Department of Health and Human Services><United States Dept. of Health and Human Services><United States National Institutes of Health><United States Public Health Service><Update><Virus><Wuhan coronavirus><active followup><anti-cancer research><anticancer research><application program interface><application programming interface><bio-markers><biobank><biologic><biologic marker><biomarker><biorepository><cancer diagnosis><cancer palliative care><cancer palliative treatment><cancer rehab><cancer rehabilitation><cancer research><clinical database><clinical research site><clinical site><conference><consultation><consults><convention><corona virus disease 2019><coronavirus disease 2019><coronavirus disease 2019 virus><coronavirus disease-19><coronavirus disease-19 virus><coronavirus infectious disease-19><customs><data acquisition><data acquisitions><data base><data de-identification><data deidentification><data depository><data exchange><data interpretation><data management><data repository><data set repository><data transfer><data transmission><dataset repository><de-identified data><deidentified data><design><designing><developmental><electronic><electronic communication><electronic device><enroll><experience><falls><follow up><follow-up><followed up><followup><hCoV19><host response><imaging><immune system response><immunoresponse><individual responsibility><information security><meeting><meetings><member><nCoV2><name><named><naming><online computer><personnel><preparations><programs><resection><sample collection><specimen collection><statistical analysis><statistics><success><summit><symposia><symposium><timeline><web based><work group><working group>